Epigenomics AG (FRA:ECX)

Germany · Delayed Price · Currency is EUR

0.8700

-0.2200 (-20.18%)

May 14, 2026, 8:13 PM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Diagnostic Kits / Equipment	24.00K		339.00K	899.00K	6.20M	842.00K
Diagnostic Kits / Equipment Growth	-		-62.29%	-85.51%	636.70%	-25.16%
Total	24.00K		339.00K	899.00K	6.20M	842.00K
Total Growth	-		-62.29%	-85.51%	636.70%	-25.16%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
North America and Asia		-	620.00K	-	-
Europe		-	279.00K	189.00K	290.00K
Europe Growth		-	47.62%	-34.83%	8.61%
North America		-	-	297.00K	531.00K
North America Growth		-	-	-44.07%	-25.63%
Asia		-	-	5.72M	21.00K
Asia Growth		-	-	27123.81%	-84.44%
Total		-	899.00K	6.20M	842.00K
Total Growth		-	-85.51%	636.70%	-25.16%

Source: S&P Global Market Intelligence.